These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22117419)

  • 1. [Arginase, nitrates, and nitrites in the blood plasma and erythrocytes in hypertension and after therapy with lisinopril and simvastatin].
    Kaminskiĭ IuG; Suslikov AV; Tikhonova LA; Galimova MKh; Ermakov GL; Tsvetkov VD; Kosenko EA
    Izv Akad Nauk Ser Biol; 2011; (5):524-31. PubMed ID: 22117419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of lisinopril and lisinopril plus simvastatin on erythrocyte and plasma arginase, nitrite, and nitrate in hypertensive patients.
    Kosenko E; Tikhonova L; Suslikov A; Kaminsky Y
    J Clin Pharmacol; 2012 Jan; 52(1):102-9. PubMed ID: 21406601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and pronounced impacts of lisinopril and lisinopril plus simvastatin on erythrocyte antioxidant enzymes.
    Kaminsky Y; Suslikov A; Kosenko E
    J Clin Pharmacol; 2010 Feb; 50(2):180-7. PubMed ID: 19841160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antioxidant enzymes in erythrocytes from hypertension patients receiving lisinopril monotherapy or combined lisinopril plus simvastatin therapy].
    Kosenko EA; Suslikov AV; Venediktova NI; Kaminskiĭ IuG
    Biomed Khim; 2011; 57(3):335-42. PubMed ID: 21863747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The nitric oxide system in patients with arterial hypertension living in high mountains].
    Kurdanova MKh; Beslaneev IA; Batyrbekova LM; Berkhamova ZA; Sarbasheva AKh; Kurdanov KhA
    Ter Arkh; 2007; 79(12):25-8. PubMed ID: 18220026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased level of nitric oxide stable metabolites in the blood of highlanders].
    Sahach VF; Doloman LB; Kotsiuruba AV; Bukhanevich OM; Kurdanov KhA; Beslanieiev IA; Bekuzarova SA
    Fiziol Zh (1994); 2002; 48(5):3-8. PubMed ID: 12449607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of agmatine on L-arginine metabolism in erythrocytes under streptozotocin-induced diabetes in rats].
    Ferents IV; Brodiak IV; Liuta MIa; Burda VA; Fedorovych AM; Sybirna NO
    Ukr Biokhim Zh (1999); 2012; 84(3):55-62. PubMed ID: 22860402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased excretion of nitric oxide in exhaled air of patients with chronic renal failure.
    Matsumoto A; Hirata Y; Kakoki M; Nagata D; Momomura Si; Sugimoto T; Tagawa H; Omata M
    Clin Sci (Lond); 1999 Jan; 96(1):67-74. PubMed ID: 9857108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic significance of nitrates and nitrites and L-arginine, in development of hepatorenal syndrome in patients with end stage alcoholic liver cirrhosis.
    Nickovic V; Kocic G; Bjelakovic G; Pavlovic R; Stojanovic I; Katanic R; Stojanovic S; Djindjic B
    Ren Fail; 2013; 35(5):633-9. PubMed ID: 23651488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin reverses the hypertension of heterozygous mice lacking cystathionine beta-synthase and apolipoprotein A-I.
    Carnicer R; Navarro MA; Guillén N; Arbonés-Mainar JM; Surra JC; Acín S; Osada J
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Mar; 377(1):35-43. PubMed ID: 18224302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-arginine catabolism is driven mainly towards nitric oxide synthesis in the erythrocytes of patients with type 2 diabetes at first clinical onset.
    Savu O; Iosif L; Bradescu OM; Serafinceanu C; Papacocea R; Stoian I
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):135-43. PubMed ID: 24675988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
    Buikema H; Monnink SH; Tio RA; Crijns HJ; de Zeeuw D; van Gilst WH
    Br J Pharmacol; 2000 Aug; 130(8):1999-2007. PubMed ID: 10952693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of HMG-CoA reductase inhibition by simvastatin on vascular dysfunction induced by lipopolysaccharide in rats.
    Alvarez de Sotomayor M; Vega S; Mingorance C; Marhuenda E; Herrera MD
    Pharmacology; 2008; 82(2):89-96. PubMed ID: 18509252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endothelial dysfunction in obese hypertensive patients].
    Lyzohub VH; Hula NM; Khomenko ZhA; Dykukha IS; Kotsiuruba AV; Bukhanevych OM; Kosiakova HV
    Lik Sprava; 2003; (1):30-3. PubMed ID: 12712605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].
    Statsenko ME; Derevianchenko MV
    Ter Arkh; 2014; 86(8):90-3. PubMed ID: 25306751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin effects on portal-systemic collaterals of portal hypertensive rats.
    Huang HC; Wang SS; Lee JY; Chen YC; Lee FY; Lin HC; Chang CC; Lee SD
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1401-9. PubMed ID: 20659230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of doxazosin on C-reactive protein plasma levels and on nitric oxide in patients with hypertension.
    Derosa G; Cicero AF; D'Angelo A; Tinelli C; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo S; Montagna L; Gravina A; Ferrari I; Galli S; Paniga S; Fogari R
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):508-12. PubMed ID: 16680063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation products of nitric oxide, NO2 and NO3, in plasma after experimental myocardial infarction.
    Akiyama K; Suzuki H; Grant P; Bing RJ
    J Mol Cell Cardiol; 1997 Jan; 29(1):1-9. PubMed ID: 9040016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy.
    Iyamu EW; Cecil R; Parkin L; Woods G; Ohene-Frempong K; Asakura T
    Br J Haematol; 2005 Nov; 131(3):389-94. PubMed ID: 16225659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.